Alloster ic compounds that stimu late Hsp90 ade- nosine triphosph atase(ATPase) activity were ration ally de- signed, showing anticancer potenc ies in the low micromo- lar to nanomo lar range. In parallel, the mode of action of these comp ounds was clarified andaquantitative model that links the dynam ic ligand -protein cross-tal ktoob- served cellular andinvitro activities was develo ped. The results suppo rt the potentia lofusing dynamics- based ap- proaches to develo porigina lmechanis m-based cancer therapeutics
Design of allosteric stimulators of the HSP90 ATPase as novel anticancer leads
I D'Annessa;E Moroni;G Colombo
2017
Abstract
Alloster ic compounds that stimu late Hsp90 ade- nosine triphosph atase(ATPase) activity were ration ally de- signed, showing anticancer potenc ies in the low micromo- lar to nanomo lar range. In parallel, the mode of action of these comp ounds was clarified andaquantitative model that links the dynam ic ligand -protein cross-tal ktoob- served cellular andinvitro activities was develo ped. The results suppo rt the potentia lofusing dynamics- based ap- proaches to develo porigina lmechanis m-based cancer therapeuticsFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
